{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:41:39Z","timestamp":1783478499222,"version":"3.55.0"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154665","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T03:49:35Z","timestamp":1688442575000},"page":"154665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance"],"prefix":"10.1016","volume":"248","author":[{"given":"Walaa A.","family":"El-Dakroury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Saeid","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.prp.2023.154665_bib1","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/cancers15112873","article-title":"Preclinical models of adrenocortical cancer","volume":"15","author":"Sedlack","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/cncr.31916","article-title":"The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity","volume":"125","author":"Chandrasekar","year":"2019","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jso.27161","article-title":"Contemporary conditional cancer\u2010specific survival rates in surgically treated adrenocortical carcinoma patients: a stage\u2010specific analysis","volume":"127","author":"Panunzio","year":"2023","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/0003134820956275","article-title":"Clinical score predicting overall survival after surgery for synchronous metastatic adrenocortical carcinoma: a surveillance, epidemiology, and end result-based study","volume":"87","author":"Wu","year":"2021","journal-title":"Am. Surg."},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: a clinician's update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2023.154665_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib9","first-page":"73","article-title":"MicroRNA-499 gene expression in egyptian type 2 diabetes mellitus patients with and without coronary heart disease","volume":"2","author":"Oraby","year":"2022","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.prp.2023.154665_bib10","article-title":"Association of miRNA-499 rs3746444 A> G genotype variants with type 2 diabetes mellitus and its coronary heart disease complication in adult Egyptian population","volume":"29","author":"Oraby","year":"2022","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib11","article-title":"MiR-216a in diabetic nephropathy: relation with autophagy and apoptosis, international journal of pharmaceutical research & allied sciences","volume":"7","author":"Elshaer","year":"2018"},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib12","doi-asserted-by":"crossref","first-page":"FSO829","DOI":"10.2144\/fsoa-2022-0074","article-title":"The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke","volume":"8","author":"Salman","year":"2022","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.prp.2023.154665_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154665_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay-a review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154665_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154665_bib17","doi-asserted-by":"crossref","unstructured":"A. Ismail, H.A. El-Mahdy, A.I. Abulsoud, A.-A.M. Sallam, M.G. Eldeib, E.G. Elsakka, M.B. Zaki, A.S. Doghish, Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review, International Journal of Biological Macromolecules (2022).","DOI":"10.1016\/j.ijbiomac.2022.10.241"},{"key":"10.1016\/j.prp.2023.154665_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 a focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: a focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib22","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib24","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154665_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-A review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib30","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154665_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.154665_bib35","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib38","article-title":"miRNAs as potential game-changers in retinoblastoma: future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib39","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 a focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol.\u00a0Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154590","article-title":"miRNAs orchestration of salivary gland cancer- particular emphasis on diagnosis, progression, and drug resistance","author":"El-Husseiny","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib41","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol.\u00a0Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: potential therapeutic and clinical applications","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib44","article-title":"miRNAs as potential game-changers in bone diseases: future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol.\u00a0Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib47","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154665_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes. Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult Egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154665_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154665_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154665_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications - a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154665_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib55","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib56","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154665_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: insights on structure variants vaccines and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154665_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154665_bib61","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"key":"10.1016\/j.prp.2023.154665_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer-A focus on signaling pathways interplay","author":"Abulsoud","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Hegazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mgene.2018.02.007","article-title":"Association of MicroRNA related single nucleotide polymorphisms 196A-2 and 499 with the risk of hepatocellular carcinoma in Egyptian patients","volume":"16","author":"Abdel-Hamid","year":"2018","journal-title":"Meta Gene"},{"issue":"14","key":"10.1016\/j.prp.2023.154665_bib65","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/cells11142234","article-title":"MicroRNAs and long non-coding RNAs in adrenocortical carcinoma","volume":"11","author":"Detomas","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.surg.2022.08.025","article-title":"Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival","volume":"173","author":"Subramanian","year":"2023","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cancers12020461","article-title":"Non-coding RNAs in adrenocortical cancer: from pathogenesis to diagnosis","volume":"12","author":"Decmann","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/cancers12030724","article-title":"Early postoperative circulating mir-483-5p is a prognosis marker for adrenocortical cancer","volume":"12","author":"Oreglia","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12020-022-03066-z","article-title":"Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand","volume":"77","author":"Perge","year":"2022","journal-title":"Endocrine"},{"issue":"21","key":"10.1016\/j.prp.2023.154665_bib70","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.3390\/cancers14215245","article-title":"Bridging the scientific gaps to identify effective treatments in adrenocortical cancer","volume":"14","author":"Michael","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154665_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.613248","article-title":"Current status and future targeted therapy in adrenocortical cancer","volume":"12","author":"Alyateem","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib72","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3390\/cancers12082198","article-title":"Key MicroRNA\u2019s and their targetome in adrenocortical cancer","volume":"12","author":"Chehade","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib73","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154665_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154665_bib77","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154665_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154665_bib79","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib80","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.prp.2023.154665_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression metastasis and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.prp.2023.154665_bib83","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"7795","key":"10.1016\/j.prp.2023.154665_bib84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib85","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154665_bib86","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154665_bib87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib88","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib89","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154665_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.154665_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib93","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"issue":"7014","key":"10.1016\/j.prp.2023.154665_bib94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154665_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib96","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154665_bib97","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154665_bib98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00438-010-0556-1","article-title":"Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production","volume":"284","author":"Miyoshi","year":"2010","journal-title":"Mol. Genet. Genom. MGG"},{"key":"10.1016\/j.prp.2023.154665_bib99","doi-asserted-by":"crossref","unstructured":"K. Ergin R. \u00c7etinkaya Regulation of microRNAs, miRNomics Springer 2022 1 32.","DOI":"10.1007\/978-1-0716-1170-8_1"},{"issue":"7149","key":"10.1016\/j.prp.2023.154665_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154665_bib101","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib102","first-page":"1952","article-title":"MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line","volume":"35","author":"da Silva","year":"2022"},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib103","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of Novel Cyanopyridones and Pyrido [2, 3-D] pyrimidines as anticancer agents with Dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154665_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154665_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib106","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154665_bib107","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154665_bib108","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154665_bib109","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: antibacterial antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.prp.2023.154665_bib111","first-page":"4734","article-title":"Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations","volume":"85","author":"De Fraipont","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib112","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12607","article-title":"Expression of LIN 28 and its regulatory micro RNA s in adult adrenocortical cancer","volume":"82","author":"Faria","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib113","first-page":"973","article-title":"LIN28\/LIN28B: an emerging oncogenic driver in cancer stem cells","volume":"45","author":"Zhou","year":"2013"},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib114","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 enhances tumorigenesis and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat. Genet."},{"issue":"19","key":"10.1016\/j.prp.2023.154665_bib115","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.3390\/cancers14194640","article-title":"Lin28 regulates cancer cell stemness for tumour progression","volume":"14","author":"Lin","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib116","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.stem.2016.05.009","article-title":"LIN28 regulates stem cell metabolism and conversion to primed pluripotency","volume":"19","author":"Zhang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.prp.2023.154665_bib117","first-page":"31","article-title":"The LIN28\/let-7 pathway in cancer","volume":"8","author":"Balzeau","year":"2017"},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib118","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/en.2007-1686","article-title":"Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells","volume":"149","author":"Romero","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib119","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer","volume":"5","author":"Feng","year":"2016","journal-title":"Biomed. Rep."},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib120","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ijc.31363","article-title":"MiR\u2010483\u20135p and miR\u2010139\u20135p promote aggressiveness by targeting N\u2010myc downstream\u2010regulated gene family members in adrenocortical cancer","volume":"143","author":"Agosta","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"14","key":"10.1016\/j.prp.2023.154665_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142234","article-title":"MicroRNAs and long non-coding RNAs in adrenocortical carcinoma","volume":"11","author":"Detomas","year":"2022","journal-title":"Cells"},{"issue":"30","key":"10.1016\/j.prp.2023.154665_bib122","doi-asserted-by":"crossref","first-page":"49191","DOI":"10.18632\/oncotarget.16788","article-title":"Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy","volume":"8","author":"Koperski","year":"2017","journal-title":"OncoTarget"},{"key":"10.1016\/j.prp.2023.154665_bib123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbiotec.2019.03.017","article-title":"Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy","volume":"297","author":"Decmann","year":"2019","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib124","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12020-019-02033-5","article-title":"IGF2 role in adrenocortical carcinoma biology","volume":"66","author":"Pereira","year":"2019","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib125","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.ygeno.2020.03.022","article-title":"Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis","volume":"112","author":"Alkorashy","year":"2020","journal-title":"Genomics"},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib126","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.25724","article-title":"MicroRNA profiling of adrenocortical tumors reveals miR\u2010483 as a marker of malignancy","volume":"117","author":"Patterson","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2010.11.027","article-title":"Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner","volume":"333","author":"Ma","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.prp.2023.154665_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2022.5430","article-title":"Altered expression of the IGF2\u2013H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma","volume":"61","author":"Scicluna","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"\u00d6zata","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2023.154665_bib130","doi-asserted-by":"crossref","unstructured":"K. Nowek E.A. Wiemer M. Jongen-Lavrencic versatile Nat. MiR. -9\/9* Hum. Cancer 9 29 2018 20838.","DOI":"10.18632\/oncotarget.24889"},{"issue":"34","key":"10.1016\/j.prp.2023.154665_bib131","doi-asserted-by":"crossref","first-page":"36675","DOI":"10.18632\/oncotarget.5383","article-title":"MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma","volume":"6","author":"Glover","year":"2015","journal-title":"Oncotarget."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib132","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAI.0000000000000117","article-title":"Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system","volume":"23","author":"Feinmesser","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib133","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"13","key":"10.1016\/j.prp.2023.154665_bib134","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1091\/mbc.e10-01-0062","article-title":"MiR-322\/424 and-503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A","volume":"21","author":"Sarkar","year":"2010","journal-title":"Mol. Biol. Cell."},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib135","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/leu.2009.246","article-title":"Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation","volume":"24","author":"Forrest","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2023.154665_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: state-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib137","first-page":"551","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013"},{"issue":"24","key":"10.1016\/j.prp.2023.154665_bib138","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483\u20135p identified as Predictors of Poor Prognosis in Adrenocortical CancerMicroRNA and Adrenocortical Carcinomas","volume":"15","author":"Soon","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101423","article-title":"ZNF367 inhibits cancer progression and is targeted by miR-195","volume":"9","author":"Jain","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib140","first-page":"19","article-title":"MALAT1: a long non\u2011coding RNA highly associated with human cancers","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154665_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2022.101972","article-title":"Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression","volume":"49","author":"El-Ashmawy","year":"2022","journal-title":"Food Biosci."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib142","first-page":"677","article-title":"Reciprocal interplay of miR-497 and MALAT1 promotes tumourigenesis of adrenocortical cancer","volume":"26","author":"Hassan","year":"2019"},{"key":"10.1016\/j.prp.2023.154665_bib143","first-page":"312","article-title":"microRNA-7: a tumor suppressor miRNA with therapeutic potential","volume":"54","author":"Kalinowski","year":"2014"},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib144","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med."},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082198","article-title":"Key MicroRNA's and Their Targetome in Adrenocortical Cancer","volume":"12","author":"Chehade","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.prp.2023.154665_bib146","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor\u2013mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2023.154665_bib147","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Metabolism, Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J. Clin. Endocrinol Metab."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib148","first-page":"744","article-title":"MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis","volume":"72","author":"Bimpaki","year":"2010"},{"key":"10.1016\/j.prp.2023.154665_bib149","doi-asserted-by":"crossref","unstructured":"Y. Wu W. Wang W. Hu W. Xu G. Xiao Q. Nie K. Ouyang S. Chen Micro -205 Suppr. Growth adrenocortical Carcinoma SW-13 Cells via Target. Bcl-2 34 6 2015 3104 3110.","DOI":"10.3892\/or.2015.4295"},{"key":"10.1016\/j.prp.2023.154665_bib150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib151","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/ijms24087513","article-title":"Impact of adipose tissue depot harvesting site on the multilineage induction capacity of male rat adipose-derived mesenchymal stem cells: an in vitro study","volume":"24","author":"El-Husseiny","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154665_bib152","doi-asserted-by":"crossref","unstructured":"L.-j Luo D.-d Wang J. Wang F. Yang J. Tang Divers. roles MiR. -335 Dev. Progress. Cancers 37 2016 15399 15410.","DOI":"10.1007\/s13277-016-5385-3"},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib153","first-page":"529","article-title":"Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours","volume":"64","author":"Schmitz","year":"2011"},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib154","first-page":"43","article-title":"Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival","volume":"173","author":"Subramanian","year":"2023"},{"key":"10.1016\/j.prp.2023.154665_bib155","doi-asserted-by":"crossref","unstructured":"L. Ye F. Wang H. Wu H. Yang Y. Yang Y. Ma A. Xue J. Zhu M. Chen J. Wang Ther., Funct. Targets MiR. -335 Cancer 14 2021 3335.","DOI":"10.2147\/OTT.S305098"},{"key":"10.1016\/j.prp.2023.154665_bib156","doi-asserted-by":"crossref","unstructured":"G. Hu Y. Wei Y. Kang Multifaceted Role MTDH\/AEG-1 Cancer Progress. \/AEG-1 Tumor Progress. 15 18 2009 5615 5620.","DOI":"10.1158\/1078-0432.CCR-09-0049"},{"key":"10.1016\/j.prp.2023.154665_bib157","doi-asserted-by":"crossref","unstructured":"J. He Y. Cao T. Su Y. Jiang L. Jiang W. Zhou C. Zhang W. Wang G. Ning Downregulation miR\u2010375 aldosterone\u2010producing Aden Promot. Tumour Cell Growth via MTDH 83 4 2015 581 589.","DOI":"10.1111\/cen.12814"},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib158","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1634\/theoncologist.2018-0849","article-title":"microRNA\u2010431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma","volume":"24","author":"Kwok","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2023.154665_bib159","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fob.2015.11.001","article-title":"MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial\u2013mensenchymal transition","volume":"5","author":"Sun","year":"2015","journal-title":"FEBS Open Bio."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib160","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1634\/theoncologist.2018-0849","article-title":"microRNA\u2010431 as a chemosensitizer and potentiator of drug activity in adrenocortical carcinoma","volume":"24","author":"Kwok","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib161","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"24","key":"10.1016\/j.prp.2023.154665_bib162","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483-5p identified as Predictors of Poor Prognosis in Adrenocortical CancerMicroRNA and Adrenocortical Carcinomas","volume":"15","author":"Soon","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib163","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jcp.2010.085621","article-title":"Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours","volume":"64","author":"Schmitz","year":"2011","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib164","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.25724","article-title":"MicroRNA profiling of adrenocortical tumors reveals miR\u2010483 as a marker of malignancy","volume":"117","author":"Patterson","year":"2011","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1549-8719.2011.00154.x","article-title":"miR\u2010210: the master hypoxamir","volume":"19","author":"Chan","year":"2012","journal-title":"Microcirculation"},{"issue":"19","key":"10.1016\/j.prp.2023.154665_bib166","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1093\/nar\/gkv908","article-title":"Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples","volume":"43","author":"Gara","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib167","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1556\/650.2018.30919","article-title":"patogenetikai \u00e9s diagnosztikai szerepe mell\u00e9kvesek\u00e9reg-carcinom\u00e1ban","volume":"159","author":"Nagy","year":"2018","journal-title":"Orv. Hetil."},{"issue":"30","key":"10.1016\/j.prp.2023.154665_bib168","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib169","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"issue":"39","key":"10.1016\/j.prp.2023.154665_bib170","doi-asserted-by":"crossref","first-page":"65525","DOI":"10.18632\/oncotarget.19118","article-title":"New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer","volume":"8","author":"Salvianti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154665_bib171","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Feige","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"30","key":"10.1016\/j.prp.2023.154665_bib172","doi-asserted-by":"crossref","first-page":"49191","DOI":"10.18632\/oncotarget.16788","article-title":"Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy","volume":"8","author":"Koperski","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib173","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/labinvest.2013.148","article-title":"Analysis of circulating microRNAs in adrenocortical tumors","volume":"94","author":"Szab\u00f3","year":"2014","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib174","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1038\/s41598-017-05777-0","article-title":"Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors","volume":"7","author":"Perge","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154665_bib175","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAI.0000000000000117","article-title":"Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system","volume":"23","author":"Feinmesser","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"9","key":"10.1016\/j.prp.2023.154665_bib176","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1210\/jc.2018-00817","article-title":"MicroRNA expression profiling in adrenal myelolipoma","volume":"103","author":"Decmann","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2023.154665_bib177","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coemr.2019.07.007","article-title":"Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures","volume":"8","author":"Grisanti","year":"2019","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2023.154665_bib179","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.prp.2023.154665_bib180","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III\u2013IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Libe","year":"2015","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2023.154665_bib181","first-page":"3130","article-title":"C. Sturgeon, Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors, Cancer: Interdisciplinary","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Int. J. Am. Cancer Soc."},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib182","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-18-0450","article-title":"Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis","volume":"179","author":"Vanbrabant","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib183","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.prp.2023.154665_bib184","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.prp.2023.154665_bib185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","article-title":"S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study","volume":"186","author":"Elhassan","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.prp.2023.154665_bib186","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fendo.2015.00195","article-title":"microRNAs as potential biomarkers in adrenocortical cancer: progress and challenges","volume":"6","author":"Cherradi","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2023.154665_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142234","article-title":"MicroRNAs and long non-coding RNAs in adrenocortical carcinoma","author":"Detomas","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154665_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030724","article-title":"Early Postoperative Circulating miR-483-5p is a prognosis marker for adrenocortical cancer","author":"Oreglia","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.prp.2023.154665_bib189","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"\u00d6zata","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/labinvest.2013.148","article-title":"Analysis of circulating microRNAs in adrenocortical tumors","volume":"94","author":"Szab\u00f3","year":"2014","journal-title":"Lab. Investig."},{"issue":"30","key":"10.1016\/j.prp.2023.154665_bib191","doi-asserted-by":"crossref","first-page":"49191","DOI":"10.18632\/oncotarget.16788","article-title":"Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy","volume":"8","author":"Koperski","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.prp.2023.154665_bib192","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.humpath.2014.04.005","article-title":"MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations","volume":"45","author":"Duregon","year":"2014","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib193","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"I.J.E.-r.c. Liko, Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib194","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/cancers14040895","article-title":"Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence","volume":"14","author":"Turai","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2023.154665_bib195","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/or.2017.5427","article-title":"New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma","volume":"37","author":"Stigliano","year":"2017","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2023.154665_bib196","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1101\/gr.7179508","article-title":"Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells","volume":"18","author":"Morin","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.prp.2023.154665_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110541","article-title":"The lncRNAs UCA1 and CRNDE target miR-145\/TLR4\/NF-\u049bB\/TNF-\u03b1 axis in acetic acid-induced ulcerative colitis model: the beneficial role of 3,3-Diindolylmethane","volume":"121","author":"El-Boghdady","year":"2023","journal-title":"Int. Immunopharmacol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:35:19Z","timestamp":1774409719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":197,"alternative-id":["S0344033823003655"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154665","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154665"}}